查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983869

静脉注射装置市场：按产品类型、材质、便携性、应用和最终用户分類的全球市场预测 – 2026-2032 年

Intravenous Equipment Market by Product Type, Material Type, Portability, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，静脉注射设备市场价值将达到 140.7 亿美元，到 2026 年将成长至 149.6 亿美元，到 2032 年将达到 215.9 亿美元，复合年增长率为 6.30%。

主要市场统计数据
基准年 2025 140.7亿美元
预计年份：2026年 149.6亿美元
预测年份 2032 215.9亿美元
复合年增长率 (%) 6.30%

全面概述了正在重塑所有医疗保健机构静脉输液治疗的临床需求、供应链现状和技术进步。

静脉注射装置领域处于临床需求与技术可能性的交汇点，受到不断变化的医疗保健格局、日益提高的感染控制要求以及对以患者为中心的护理模式的需求的深刻影响。临床医生依赖各种装置和耗材来安全有效地输注液体、药物和营养，而耐用输液泵与一次性配件之间的配合仍然是日常实践的核心。随着住院时间的缩短以及门诊和居家照护的扩展，兼顾便携性、准确性和成本效益已成为医疗服务提供者和製造商的策略重点。

智慧型设备的整合、向门诊和居家照护的转变以及对永续性的日益重视，正在重新定义静脉注射设备的设计、采购和服务模式。

静脉注射设备领域正经历着一场变革，这主要得益于三大因素的交汇：技术进步、照护模式的转变以及对监管和永续性日益增长的期望。整合安全软体和互通性的智慧型输液帮浦正从选购功能转变为先进医疗环境中的必备要素，这迫使原始设备製造商 (OEM) 和医院 IT 团队投资于设备管理平台和双向资料流。同时，居家输液和门诊护理的日益普及推动了对高度便携、易于使用的设备以及专为非临床环境设计的耗材的需求，从而再次凸显了培训、远端监控和供应物流的重要性。

评估近期关税政策对静脉注射装置生态系统中的筹资策略、供应商韧性、采购行为和产品生命週期经济的持久影响。

近期政策週期中实施的贸易措施对静脉注射器材的供应链策略、成本模型和采购决策产生了累积影响。关税带来的成本压力迫使製造商和经销商重新思考其全球采购结构，许多企业加快了生产回流的步伐，并对低关税地区的二级供应商进行认证，以维持盈利能力和准时交货的可靠性。作为应对措施，医疗机构和集团采购组织正在收紧合约条款，提高库存可视性要求，并优先考虑能够证明其冗余性和短期交货保证的供应商。

详细的細項分析揭示了产品系列、最终用户环境、临床应用、一次性选项、便携性要求和材料选择如何决定采购和设计优先顺序。

细分市场层面的趋势揭示了不同产品系列、最终用户、应用、一次性用品选择、便携性偏好和材料选择等方面的驱动因素和决策标准各不相同。在产品类型内部，诸如滴壶、延长管、过滤器和输液器等配件的选择通常取决于采购週期，采购週期优先考虑无菌保证、兼容性和单位成本效益；而套管的选择（带翼和不带翼两种类型）则取决于治疗环境和临床医生的偏好。导管的选择是基于临床因素，中央静脉导管、週边静脉导管和周边置入的中央静脉导管分别适用于不同的治疗路径和感染控制系统。输液帮浦是技术权衡范围最广的领域。弹性体帮浦为门诊输液提供便利性和一次性使用性；胰岛素帮浦需要挽救生命的精准度和符合人体工学的操作；注射式帮浦满足精确小容量给药的需求；而容量帮浦在高危险环境下的控制给药中发挥核心作用。

影响製造业、监管方法和部署模式的美洲、欧洲、中东和非洲以及亚太地区的区域市场特征和战略重点。

区域趋势对整个静脉注射器材市场的製造、监管路径和部署模式产生显着影响。在美洲，大规模综合医疗保健系统和健全的私人保险体系推动了对兼顾临床疗效和成本控制的解决方案的需求。该市场青睐那些能够提供强大服务网路、相容耗材以及与电子健康记录成熟互通性的供应商。在欧洲、中东和非洲，不同的监管环境和不断变化的报销机制要求企业制定个人化的打入市场策略，其中公私混合体系通常优先考虑以竞标为基础的采购方式，强调产品生命週期价值和符合当地安全标准。在亚太地区，对医院基础设施的快速投资、对居家医疗日益增长的关注以及充满活力的製造业基地，使该地区成为重要的需求中心和全球生产网络的关键枢纽。

概述竞争格局，其中设备智慧、生命週期服务和供应链敏捷性的创新将决定哪些公司能够获得长期的商业性和临床优势。

静脉注射设备产业的竞争动态取决于产品创新、服务能力和供应可靠性方面的差异化。主要企业正日益将卓越的硬体效能与支援安全性、数据分析和远端设备管理的软体功能相结合。售后服务和耗材仍然是维繫客户关係的重要因素，而提供透明的生命週期成本模型、及时的技术支援和以临床医生为中心的培训的供应商则能确保长期的采购优势。策略伙伴关係、与医疗机构的共同开发契约以及对人因工程研究的投资，能够提升产品与市场的契合度，并在细分市场中建立稳固的防御地位。

医疗设备製造商和供应商的实用策略重点是提高设备互通性、供应弹性、永续性以及将商业性奖励与临床结果一致的服务模式。

产业领导企业应采取多管齐下的策略，使产品开发、商业模式和业务永续营运与不断变化的临床和采购需求保持一致。优先投资于互通性标准和以使用者为中心的设计，并确保输液帮浦及其配件能够无缝整合到电子健康记录和临床工作流程中，将有助于减少警报疲劳，并提高输液通讯协定的依从性。同时，采购管道多元化和本地供应商认证将有助于降低贸易政策变化带来的风险，并制定支援库存可见性和快速补货的合约条款。将完善的培训和远端支援功能整合到商业服务中，将增强使用者信心，尤其是在临床监管分散的门诊和居家照护环境中。

方法论的透明度描述了一种基于三角测量的调查方法，该方法整合了对临床医生的访谈、监管审查、技术规范分析和供应链场景测试。

本研究采用混合方法，结合定性相关人员访谈、技术文献综述、监管分析和供应链图谱，并对研究结果进行三角检验。一级资讯来源包括与急诊、门诊和家庭护理机构的临床医生、采购经理、临床工程师和生产主管进行的结构化访谈，以了解实际决策标准和营运限制。二级资讯来源包括医疗设备监管指南、同行评审的临床研究和製造商的技术规范，以检验性能声明和安全考虑。

全面观点强调需要将医疗设备智慧、供应可靠性和永续实践融入长期静脉注射器材策略。

总之，静脉注射装置策略如今面临多方面的挑战，不仅包括装置性能，还包括连接性、供应链韧性和环境因素。临床医生和采购经理面临着相互衝突的优先事项：既要确保病人安全和给药准确性，也要控制总成本和维持营运连续性。最成功的市场参与企业将是那些能够将产品创新与切实可行的服务交付和透明的供应策略相结合的企业，从而使医疗服务提供者能够在不损害安全性和可及性的前提下，满足不断发展的医疗模式的需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章静脉注射装置市场：依产品类型划分

  • 配件
    • 点滴室
    • 延长管
    • 筛选
    • 点滴器
  • 套管
    • 没有翅膀
    • 长着翅膀
  • 导管
    • 中央静脉
    • 外围
    • 周边置入的中央静脉导管
  • 点滴帮浦
    • 弹性体泵
    • 胰岛素帮浦
    • 注射式帮浦
    • 容积式泵

第九章：静脉注射器材市场：依材料类型划分

  • 聚烯
  • 聚氨酯
  • 聚氯乙烯

第十章静脉注射设备市场－可携式

  • 可携式的
  • 固定式

第十一章静脉注射装置市场：依应用划分

  • 麻醉
  • 重症监护
  • 营养疗法
  • 肿瘤学
  • 疼痛管理

第十二章静脉注射设备市场：依最终用户划分

  • 门诊治疗
    • 诊所
    • 诊断中心
  • 居家医疗
  • 医院
    • 一般的
    • 专科诊所

第十三章静脉注射装置市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章静脉注射器材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章静脉注射器材市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国静脉注射器材市场

第十七章：中国静脉注射器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abcam Inc.
  • Advin Health Care
  • Angel Electronic Equipment Co., Ltd.
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CODAN ARGUS AG
  • Cook Group Incorporated
  • Freudenberg Medical, LLC
  • Henry Schein, Inc.
  • ICU Medical, Inc
  • Ivenix Inc.
  • Merck KGaA
  • Novo Nordisk A/S
  • Pfizer Inc.
  • QIAGEN
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-F6513A06BEE9

The Intravenous Equipment Market was valued at USD 14.07 billion in 2025 and is projected to grow to USD 14.96 billion in 2026, with a CAGR of 6.30%, reaching USD 21.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.07 billion
Estimated Year [2026] USD 14.96 billion
Forecast Year [2032] USD 21.59 billion
CAGR (%) 6.30%

A comprehensive orientation to the clinical imperatives, supply chain realities, and technological trajectories that are reshaping intravenous therapy delivery across care settings

The intravenous equipment arena stands at the intersection of clinical necessity and technological possibility, shaped by changing care settings, heightened infection control expectations, and accelerating demand for patient-centric delivery models. Clinicians rely on a broad array of devices and consumables to deliver fluids, medications, and nutrition safely and effectively, and the interplay between durable infusion pumps and single-use accessories remains central to daily practice. As inpatient stays shorten and outpatient and home-based care expand, the balance between portability, precision, and cost-efficiency has become a strategic priority for providers and manufacturers alike.

Beyond clinical dynamics, supply chain resilience and regulatory rigor have moved to the forefront of buyer criteria. Health systems and procurement leaders increasingly evaluate not only unit price but also lifecycle costs, service continuity, and material compliance. Simultaneously, innovation in pump intelligence, connectivity, and materials science is redefining product roadmaps and commercial conversations. This introduction frames the report's exploration of clinical trends, procurement imperatives, and product evolution, providing a foundation for actionable insights across stakeholders involved in intravenous therapy delivery.

How smart device integration, care delivery migration to outpatient and home settings, and sustainability priorities are jointly redefining intravenous equipment design, procurement, and service models

The landscape for intravenous equipment is undergoing transformative shifts driven by three converging forces: technological advancement, care model migration, and heightened regulatory and sustainability expectations. Smart infusion pumps with integrated safety software and interoperability capabilities are moving from optional enhancements to core requirements in higher acuity settings, prompting OEMs and hospital IT teams to invest in device management platforms and bidirectional data flows. At the same time, the proliferation of home infusion and ambulatory care has elevated demand for portable, user-friendly devices and single-use accessories designed for nonclinical environments, which places new emphasis on training, remote monitoring, and supply logistics.

Material innovation and environmental considerations are also driving change. Device designers and procurement teams are increasingly prioritizing alternatives to legacy materials to address concerns about plasticizers and waste management. Meanwhile, manufacturers are reconfiguring production footprints and supplier networks in response to trade policy shifts and resilience planning. Collectively, these shifts are not isolated; they create feedback loops in which clinical preferences, procurement policies, and regulatory guidance accelerate adoption of particular form factors and materials, thereby influencing OEM development priorities and aftermarket service models.

Assessing the persistent effects of recent tariff policies on sourcing strategies, supplier resilience, procurement behavior, and product lifecycle economics within the intravenous equipment ecosystem

Trade measures implemented in recent policy cycles have exerted a cumulative influence on supply chain strategies, costing models, and sourcing decisions for intravenous equipment. Tariff-driven cost pressures have compelled manufacturers and distributors to re-evaluate global sourcing mixes, with many accelerating reshoring efforts or qualifying secondary suppliers in lower-tariff jurisdictions to preserve margin and delivery reliability. Health systems and group purchasing organizations have responded by tightening contract terms, extending inventory visibility requirements, and placing a premium on suppliers that can demonstrate redundancy and near-term delivery assurances.

These dynamics also shape product roadmaps. When procurement faces elevated input costs, buyers tend to prioritize consumables with predictable pricing and durable equipment with service agreements that smooth lifecycle expenses. In addition, tariffs can influence the economics of material substitution and manufacturing automation, incentivizing investment in higher-value processes that reduce labor intensity or lower tariff exposure. Mitigation strategies adopted by market participants include strategic stockpiling, renegotiation of supply contracts, and enhanced collaboration between clinical engineering and procurement to validate clinically equivalent alternatives. Over time, such adjustments alter competitive positioning: suppliers that can transparently manage cross-border complexity and provide consistent clinical support gain relative advantage in tender processes and long-term partnerships.

In-depth segmentation analysis revealing how product families, end-user settings, clinical applications, disposability choices, portability demands, and material selections determine procurement and design priorities

Segment-level dynamics reveal distinct drivers and decision criteria across product families, end users, applications, disposability choices, portability preferences, and material selection. Within product types, accessories such as drip chambers, extension tubing, filters, and infusion sets are often governed by procurement cycles that prize sterility assurance, compatibility, and unit economics, whereas cannula choices between non-winged and winged variants hinge on procedural context and clinician preference. Catheter selection is clinically driven, with central, peripheral, and peripherally inserted central catheters each serving different care pathways and infection control regimes. Infusion pumps present the broadest range of technical trade-offs: elastomeric pumps offer simplicity and disposability for ambulatory infusion, insulin pumps demand life-critical accuracy and user ergonomics, syringe pumps address small-volume precision needs, and volumetric pumps are central to controlled delivery in higher acuity settings.

End-user context further shapes product adoption and service models. Ambulatory care settings such as clinics and diagnostic centers focus on throughput, ease of use, and disposability to minimize turnover risk, while home healthcare providers prioritize portability, patient education, and remote monitoring capabilities. Hospitals, whether general or specialty, invest in interoperability, alarm management, and preventive maintenance programs to protect patient safety and asset uptime. Application areas like anesthesia, critical care, nutrition therapy, oncology, and pain management impose distinct performance and regulatory expectations that influence purchasing decisions and vendor selection. The disposable versus reusable calculus is informed by infection control protocols, total cost of ownership analyses, and environmental policy. Portability considerations create a bifurcation between portable devices optimized for mobility and stationary systems designed for integration into clinical workflows. Material selection among polyolefin, polyurethane, and polyvinyl chloride reflects trade-offs between flexibility, chemical compatibility, biocompatibility, and regulatory scrutiny. Understanding these intersecting segmentation vectors enables manufacturers and purchasers to align product specifications with clinical workflows and procurement priorities, and to design service models that respond to the nuanced needs of each segment.

Regional market signatures and strategic priorities across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence manufacturing, regulatory approach, and adoption patterns

Regional dynamics have profound implications for manufacturing, regulatory pathways, and adoption patterns across the intravenous equipment landscape. In the Americas, large integrated health systems and a robust private payer environment create demand for solutions that combine clinical performance with cost containment; this market favors suppliers that offer strong service networks, compatible consumables, and demonstrated interoperability with electronic health records. Across Europe, the Middle East, and Africa, regulatory diversity and variable reimbursement landscapes require tailored market entry strategies, and hybrid public-private systems often prioritize tender-based procurement that emphasizes total lifecycle value and compliance with regional safety standards. In the Asia-Pacific region, rapid investment in hospital infrastructure, a growing emphasis on home healthcare, and a dynamic manufacturing base position the region as both a major demand center and a critical node in global production networks.

Each region also presents distinct logistical and competitive challenges. The Americas' emphasis on documented service performance and bundled maintenance agreements raises the bar for suppliers seeking long-term contracts. Europe, the Middle East, and Africa demand nuanced regulatory navigation and an ability to serve heterogeneous clinical contexts, from high-acuity urban centers to resource-constrained facilities. Asia-Pacific's pace of technological adoption and its role in component manufacturing create opportunities for strategic partnerships, joint development, and cost-competitive sourcing, while also requiring attention to local compliance regimes and language of clinical engagement. Recognizing these regional signatures enables companies to prioritize investments and tailor value propositions to meet the expectations of clinicians, procurement teams, and regulators across diverse markets.

Competitive landscape overview where innovation in device intelligence, lifecycle services, and supply chain agility determines who captures long-term commercial and clinical advantage

Competitive dynamics within the intravenous equipment space are defined by differentiation along product innovation, service capability, and supply reliability. Leading companies increasingly combine hardware excellence with software-enabled features that support safety, analytics, and remote device management. Aftermarket services and consumables remain a durable source of customer lock-in, and providers that offer transparent lifecycle cost models, rapid technical support, and clinician-focused training secure long-term procurement advantages. Strategic partnerships, co-development arrangements with clinical institutions, and investments in human factors research bolster product-market fit and create defensible positions in specialty segments.

At the same time, competitive pressure incentivizes operational efficiency and nimble supply chain strategies. Companies that excel in supplier diversification, manufacturing flexibility, and regulatory agility can respond more rapidly to policy changes and emergent clinical needs. The convergence of clinical software and connected devices opens opportunities for new commercial models, including subscription-based service offerings that align revenue with device uptime and performance. Given these dynamics, firms that balance R&D investment in smart device capabilities with disciplined commercial execution and robust post-sale support will be best positioned to capture durable customer relationships and to expand into adjacent care settings.

Practical strategic priorities for manufacturers and providers to enhance device interoperability, supply resilience, sustainability, and service models that align commercial incentives with clinical outcomes

Industry leaders should adopt a multi-pronged strategy that aligns product development, commercial models, and operational resilience with evolving clinical and procurement expectations. Prioritize investments in interoperability standards and user-centered design to ensure that pumps and accessories integrate seamlessly into electronic health records and clinical workflows, thereby reducing alarm fatigue and improving adherence to infusion protocols. Simultaneously, diversify sourcing and qualify regional suppliers to reduce exposure to trade policy volatility, while developing contractual terms that support inventory visibility and rapid replenishment. Embedding robust training and remote support capabilities into commercial offerings will enhance user confidence, particularly in ambulatory and home-care contexts where clinical oversight is distributed.

Leaders should also evaluate sustainability and material substitution as strategic differentiators, exploring transitions away from legacy plastics where clinically and regulatorily feasible. Consider novel service models that shift part of the value proposition from unit sales to outcome-based contracts or managed device services, aligning incentives across providers and suppliers. Finally, cultivate cross-functional engagement between clinical engineering, procurement, and product teams to accelerate adoption of clinically validated alternatives and to ensure procurement decisions reflect both safety imperatives and long-term cost dynamics. These measures collectively strengthen competitive position and enable organizations to respond nimbly to regulatory and market shifts.

Methodological transparency describing a triangulated research approach that integrates clinician interviews, regulatory review, technical specification analysis, and supply chain scenario testing

This research synthesizes insights from a mixed-methods approach combining qualitative stakeholder interviews, technical literature review, regulatory analysis, and supply chain mapping to triangulate findings. Primary inputs included structured conversations with clinicians across acute, ambulatory, and home settings, procurement leaders, clinical engineers, and manufacturing executives to capture real-world decision criteria and operational constraints. Secondary sources encompassed device guidance from regulatory authorities, peer-reviewed clinical studies, and manufacturer technical specifications to validate performance claims and safety considerations.

Analytical methods involved cross-validating interview themes with documented policies and device specifications, and constructing scenario-based assessments to stress-test supplier resilience and product fit across diverse care pathways. Limitations of the methodology include potential variability in regional regulatory interpretation and the pace of technological adoption in specific clinical niches. To mitigate these factors, findings were subjected to iterative validation with independent clinical advisors and procurement specialists to ensure relevance and practical applicability for decision-makers seeking actionable intelligence.

Summative perspective emphasizing the need to integrate device intelligence, supply reliability, and sustainable practices into long-term intravenous equipment strategies

In conclusion, intravenous equipment strategy is now a multidimensional challenge that extends beyond device performance to encompass connectivity, supply chain resilience, and environmental stewardship. Clinicians and procurement leaders face competing priorities: ensuring patient safety and precision of delivery while managing total cost and operational continuity. The most successful market participants will be those that harmonize product innovation with practical service offerings and transparent supply strategies, enabling providers to meet the demands of shifting care models without compromising safety or accessibility.

Decision-makers should view current market dynamics as an opportunity to rearchitect relationships across the value chain, privileging partners who demonstrate both clinical empathy and operational reliability. By aligning procurement criteria with long-term device stewardship and by adopting service-oriented commercial models, stakeholders can reduce friction in device adoption and create pathways for sustained improvement in infusion safety and patient experience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Drip Chambers
    • 8.1.2. Extension Tubing
    • 8.1.3. Filters
    • 8.1.4. Infusion Sets
  • 8.2. Cannula
    • 8.2.1. Non Winged
    • 8.2.2. Winged
  • 8.3. Catheters
    • 8.3.1. Central
    • 8.3.2. Peripheral
    • 8.3.3. Peripherally Inserted Central
  • 8.4. Infusion Pumps
    • 8.4.1. Elastomeric Pumps
    • 8.4.2. Insulin Pumps
    • 8.4.3. Syringe Pumps
    • 8.4.4. Volumetric Pumps

9. Intravenous Equipment Market, by Material Type

  • 9.1. Polyolefin
  • 9.2. Polyurethane
  • 9.3. Polyvinyl Chloride

10. Intravenous Equipment Market, by Portability

  • 10.1. Portable
  • 10.2. Stationary

11. Intravenous Equipment Market, by Application

  • 11.1. Anesthesia
  • 11.2. Critical Care
  • 11.3. Nutrition Therapy
  • 11.4. Oncology
  • 11.5. Pain Management

12. Intravenous Equipment Market, by End User

  • 12.1. Ambulatory Care
    • 12.1.1. Clinics
    • 12.1.2. Diagnostic Centers
  • 12.2. Home Healthcare
  • 12.3. Hospital
    • 12.3.1. General
    • 12.3.2. Specialty Clinics

13. Intravenous Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intravenous Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intravenous Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intravenous Equipment Market

17. China Intravenous Equipment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abcam Inc.
  • 18.6. Advin Health Care
  • 18.7. Angel Electronic Equipment Co., Ltd.
  • 18.8. Argon Medical Devices, Inc.
  • 18.9. B. Braun SE
  • 18.10. Baxter International, Inc.
  • 18.11. Becton, Dickinson and Company
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. CODAN ARGUS AG
  • 18.15. Cook Group Incorporated
  • 18.16. Freudenberg Medical, LLC
  • 18.17. Henry Schein, Inc.
  • 18.18. ICU Medical, Inc
  • 18.19. Ivenix Inc.
  • 18.20. Merck KGaA
  • 18.21. Novo Nordisk A/S
  • 18.22. Pfizer Inc.
  • 18.23. QIAGEN
  • 18.24. Siemens AG
  • 18.25. Smith & Nephew PLC
  • 18.26. Stryker Corporation
  • 18.27. Teleflex Incorporated.
  • 18.28. Terumo Corporation
  • 18.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 228. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 229. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 231. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 264. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 265. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 277. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 279. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 284. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)